Hegewald Medizinprodukte GmbH

Hegewald Medizinprodukte GmbH specializes in disposable bioreactors, including systems like the MiXi, MIB, and MIBMIX series. These devices are designed for single-use applications in laboratory and industrial settings, supporting tasks such as cell culture, expansion, perfusion, and bioprocessing. They are tailored for research and pharmaceutical workflows where sterile, contamination-free environments are critical.

Hegewald Medizinprodukte GmbH is based in Germany, which places its devices under the jurisdiction of the European Union’s Medical Device Regulations (MDR). Since its products are classified as Class I devices, they must comply with EU requirements for safety, performance, and traceability. The company registers its devices in the EU’s official database, eudamed, to meet transparency obligations under MDR.

Hegewald Medizinprodukte GmbH’s devices are listed in the eudamed database, which is the EU’s central registry for medical devices. This registration ensures visibility and compliance with EU Medical Device Regulation (MDR) requirements, allowing stakeholders like healthcare providers and regulators to verify the manufacturer and device details.

Hegewald’s disposable bioreactors fall under Class I classification according to the EU Medical Device Regulation (MDR). This classification is determined by factors such as the device’s risk profile, intended use, and lack of invasive or high-risk features. Class I devices typically require less stringent scrutiny than higher-risk classes but still must meet basic safety, performance, and labeling requirements to ensure compliance with EU regulations.